Literature DB >> 24710410

miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM.

Qiancheng Song1, Yuanfei Xu1, Cuilan Yang1, Zhenguo Chen1, Chunhong Jia1, Juan Chen1, Yue Zhang1, Pinglin Lai1, Xiaorong Fan1, Xuan Zhou1, Jun Lin1, Ming Li1, Wenli Ma1, Shenqiu Luo1, Xiaochun Bai2.   

Abstract

The nodal regulatory properties of microRNAs (miRNA) in metastatic cancer may offer new targets for therapeutic control. Here, we report that upregulation of miR-483-5p is correlated with the progression of human lung adenocarcinoma. miR-483-5p promotes the epithelial-mesenchymal transition (EMT) accompanied by invasive and metastatic properties of lung adenocarcinoma. Mechanistically, miR-483-5p is activated by the WNT/β-catenin signaling pathway and exerts its prometastatic function by directly targeting the Rho GDP dissociation inhibitor alpha (RhoGDI1) and activated leukocyte cell adhesion molecule (ALCAM), two putative metastasis suppressors. Furthermore, we found that downregulation of RhoGDI1 enhances expression of Snail, thereby promoting EMT. Importantly, miR-483-5p levels are positively correlated with β-catenin expression, but are negatively correlated with the levels of RhoGDI1 and ALCAM in human lung adenocarcinoma. Our findings reveal that miR-483-5p is a critical β-catenin-activated prometastatic miRNA and a negative regulator of the metastasis suppressors RhoGDI1 and ALCAM. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24710410     DOI: 10.1158/0008-5472.CAN-13-2193

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  69 in total

1.  Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach.

Authors:  Li Yan; Demin Jiao; Huizhen Hu; Jian Wang; Xiali Tang; Jun Chen; Qingyong Chen
Journal:  Exp Biol Med (Maywood)       Date:  2016-11-14

2.  Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.

Authors:  Ute Warnecke-Eberz; Seung-Hun Chon; Arnulf H Hölscher; Uta Drebber; Elfriede Bollschweiler
Journal:  Tumour Biol       Date:  2015-01-29

3.  Intra-articular Delivery of Antago-miR-483-5p Inhibits Osteoarthritis by Modulating Matrilin 3 and Tissue Inhibitor of Metalloproteinase 2.

Authors:  Hua Wang; Haiyan Zhang; Qiuyi Sun; Yun Wang; Jun Yang; Jincheng Yang; Tao Zhang; Shenqiu Luo; Liping Wang; Yu Jiang; Chun Zeng; Daozhang Cai; Xiaochun Bai
Journal:  Mol Ther       Date:  2017-01-27       Impact factor: 11.454

4.  Peripheral lung adenocarcinomas harboring epithelial growth factor receptor mutations with microRNA-135b overexpression are more likely to invade visceral pleura.

Authors:  Hanbo Le; Xiaoling Wang; Yao Zha; Jie Wang; Wangyu Zhu; Zhinan Ye; Xiaoguang Liu; Haijie Ma; Yongkui Zhang
Journal:  Oncol Lett       Date:  2017-10-16       Impact factor: 2.967

5.  A novel small-molecule compound diaporine A inhibits non-small cell lung cancer growth by regulating miR-99a/mTOR signaling.

Authors:  Yuxian Song; Huan Dou; Ping Wang; Shuli Zhao; Tingting Wang; Wei Gong; Junli Zhao; Erguang Li; Renxiang Tan; Yayi Hou
Journal:  Cancer Biol Ther       Date:  2014-07-21       Impact factor: 4.742

6.  [A method for efficient transduction of miR-483-5p in the kidney of mice].

Authors:  Ying Xia; Xue-Juan Zhou; Wen-Qing Gu; Yan-Yan Zhao; Xiao Xiao; Xiao-Chun Bai; Jun Liu; Ming Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-02-20

Review 7.  MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy.

Authors:  Peter Igaz; Ivan Igaz; Zoltán Nagy; Gábor Nyírő; Peter M Szabó; András Falus; Attila Patócs; Károly Rácz
Journal:  Cell Mol Life Sci       Date:  2014-10-09       Impact factor: 9.261

8.  Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.

Authors:  Mingchao Wang; Yin Sun; Junjie Xu; Jieyang Lu; Kefeng Wang; Dong-Rong Yang; Guosheng Yang; Gonghui Li; Chawnshang Chang
Journal:  Int J Cancer       Date:  2018-04-02       Impact factor: 7.396

9.  miR-488 acts as a tumor suppressor gene in gastric cancer.

Authors:  Yan Zhao; Guifang Lu; Xiquan Ke; Xinlan Lu; Xin Wang; Hongxia Li; Mudan Ren; Shuixiang He
Journal:  Tumour Biol       Date:  2016-01-06

10.  MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.

Authors:  Jun Zeng; Min Wei; Rong Shi; Cuixia Cai; Xinrui Liu; Taoping Li; Wenli Ma
Journal:  Tumour Biol       Date:  2015-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.